Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study.

@article{Rengan2012EffectOH,
  title={Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study.},
  author={Ramesh Rengan and Nandita Mitra and Kaijun Liao and Katrina Armstrong and Anil Vachani},
  journal={The Lancet. Oncology},
  year={2012},
  volume={13 12},
  pages={
          1203-9
        }
}
  • Ramesh Rengan, Nandita Mitra, +2 authors Anil Vachani
  • Published in The Lancet. Oncology 2012
  • Medicine
  • BACKGROUND HIV-infected patients with lung cancer have been reported to have poorer survival than uninfected patients. Whether this outcome holds true in the era of highly active antiretroviral therapy (HAART) is unclear. We examined the effect of HIV infection on clinical outcome in patients with lung cancer who are also receiving HAART. METHODS Patients diagnosed with non-small-cell lung cancer (NSCLC) from Jan 1, 2000, to Dec 31, 2005, with or without HIV infection were identified by… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 26 CITATIONS

    Prognosis in HIV-infected patients with non-small cell lung cancer

    VIEW 6 EXCERPTS
    CITES BACKGROUND & RESULTS
    HIGHLY INFLUENCED

    Lung cancer in HIV-infected patients

    VIEW 5 EXCERPTS
    CITES RESULTS
    HIGHLY INFLUENCED